NC
CVET

Nicholas Company’s Covetrus, Inc. Common Stock CVET Stock Holding History

Nicholas Company’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-386,000
Closed -$6.48M – 236
2022
Q1 		$6.48M Buy
386,000
+390
+0.1% +$6.82K 0.12% 188
2021
Q4 		$7.7M Buy
385,610
+32,380
+9% +$610K 0.13% 181
2021
Q3 		$6.41M Buy
353,230
+67,105
+23% +$1.54M 0.11% 198
2021
Q2 		$7.72M Buy
286,125
+27,445
+11% +$768K 0.14% 172
2021
Q1 		$7.75M Buy
258,680
+10,290
+4% +$351K 0.14% 173
2020
Q4 		$7.14M Buy
+248,390
New +$6.7M 0.14% 177

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicholas Company's CVET Position: Q2 2022 in Review

Nicholas Company sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 386,000 shares — an estimated $6.48M sold.

Nicholas Company first reported a position in CVET in Q4 2020 and held it in 6 quarters. The position peaked at $7.75M in Q1 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • Nicholas Company reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nicholas Company sold 386,000 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $6.48M.
  • Nicholas Company first reported a position in Covetrus, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Nicholas Company's Covetrus, Inc. Common Stock position peaked at $7.75M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Nicholas Company's 13F filing for Q2 2022, filed 26 Jul 2022.